<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.8'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//bioresearchhouse.kr/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://bioresearchhouse.kr/alnylam-pharmaceuticals-alny-%ec%99%84%ec%a0%84-%eb%b6%84%ec%84%9d-rnai-%ec%b9%98%eb%a3%8c%ec%a0%9c-4%ec%a2%85-%ec%8a%b9%ec%9d%b8-%eb%8b%a4%ec%9d%8c-%ed%83%80%ea%b9%83%ec%9d%80-%ec%8b%ac/</loc>
  <lastmod>2026-05-28T00:52:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BioResearch House</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:title>Alnylam Pharmaceuticals (ALNY) 완전 분석 — RNAi 치료제 4종 승인, 다음 타깃은 심혈관·비만</news:title>
   <news:publication_date>2026-05-28T00:52:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
